Small Lymphocytic Lymphoma

Pirtobrutinib Shows Promise as a Novel CLL_SLL Treatment for Patients Previously Treated with BTK Inhibitors - Lates USA Pharma News By Pharmtales

Pirtobrutinib Shows Promise as a Novel CLL/SLL Treatment for Patients Previously Treated with BTK Inhibitors

SG Tylor

Source – Eli Lilly On July 6, 2023,  Eli Lilly and Company’s oncology unit announced that The New England Journal ...